Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
11226
CALL
GraniteShares HIPS US High Income ETF
HIPS
$103M
| $114K | ﹤0.01% |
+8,900
| New | +$115K |
2024 Q4
0 quarters
|
|
|
KALV
11227
CALL
DELISTED
KalVista Pharmaceuticals
KALV
| $114K | ﹤0.01% |
13,500
+11,600
| +611% | +$120K |
2022 Q1
11 quarters
|
|
|
PML
11228
PIMCO Municipal Income Fund II
PML
$430M
| $114K | ﹤0.01% |
+14,133
| New | +$124K |
2024 Q4
0 quarters
|
|
11229
Maravai LifeSciences
MRVI
$1.11B
| $114K | ﹤0.01% |
+20,969
| New | +$135K |
2024 Q4
0 quarters
|
|
11230
PUT
Park Aerospace
PKE
$636M
| $114K | ﹤0.01% |
7,800
+7,200
| +1,200% | +$104K |
2024 Q3
1 quarter
|
|
11231
CALL
WidePoint Corp
WYY
$70.1M
| $114K | ﹤0.01% |
23,600
+17,900
| +314% | +$77.4K |
2024 Q3
1 quarter
|
|
11232
PUT
Pennant Group
PNTG
$1.38B
| $114K | ﹤0.01% |
4,300
+1,400
| +48% | +$44.1K |
2022 Q4
8 quarters
|
|
11233
CALL
Seanergy Maritime Holdings
SHIP
$374M
| $114K | ﹤0.01% |
16,400
-3,700
| -18% | -$33.2K |
2023 Q2
6 quarters
|
|
|
AMBR
11234
Amber International Holding Ltd
AMBR
$215M
| $114K | ﹤0.01% |
12,171
-3,862
| -24% | -$19.1K |
2024 Q2
2 quarters
|
|
|
AGD
11235
abrdn Global Dynamic Dividend Fund
AGD
$292M
| $114K | ﹤0.01% |
+11,622
| New | +$119K |
2024 Q4
0 quarters
|
|
11236
PUT
Citizens
CIA
$176M
| $114K | ﹤0.01% |
28,400
+7,600
| +37% | +$34.2K |
2024 Q2
2 quarters
|
|
11237
PUT
State Street SPDR S&P China ETF
GXC
$448M
| $114K | ﹤0.01% |
1,500
+600
| +67% | +$48K |
2024 Q3
1 quarter
|
|
11238
PUT
OptimizeRx
OPRX
$161M
| $114K | ﹤0.01% |
23,400
+5,300
| +29% | +$29.6K |
2020 Q4
16 quarters
|
|
11239
IRIDEX
IRIX
$15.4M
| $114K | ﹤0.01% |
67,653
+17,377
| +35% | +$28.7K |
2022 Q4
8 quarters
|
|
|
HTT
11240
PUT
High Templar Tech Ltd
HTT
$351M
| $114K | ﹤0.01% |
40,300
-7,600
| -16% | -$19.2K |
2024 Q2
2 quarters
|
|
11241
PUT
Vanguard Russell 1000 Growth ETF
VONG
$48.2B
| $114K | ﹤0.01% |
1,100
-900
| -45% | -$91.1K |
2023 Q1
7 quarters
|
|
|
ONIT
11242
PUT
Onity Group
ONIT
$227M
| $114K | ﹤0.01% |
3,700
+1,800
| +95% | +$55.7K |
2021 Q3
13 quarters
|
|
11243
PUT
RELX
RELX
$60B
| $114K | ﹤0.01% |
2,500
-2,300
| -48% | -$108K |
2022 Q4
8 quarters
|
|
|
B
11244
CALL
DELISTED
Barnes Group Inc.
B
| $113K | ﹤0.01% |
2,400
-4,500
| -65% | -$209K |
2022 Q4
8 quarters
|
|
|
KZR
11245
DELISTED
Kezar Life Sciences
KZR
| $113K | ﹤0.01% |
16,870
-7,676
| -31% | -$57.2K |
2019 Q1
23 quarters
|
|
11246
PUT
Renaissance IPO ETF
IPO
$151M
| $113K | ﹤0.01% |
2,600
-1,600
| -38% | -$71.8K |
2020 Q4
16 quarters
|
|
11247
Invesco NASDAQ Next Gen 100 ETF
QQQJ
$1.19B
| $113K | ﹤0.01% |
3,666
-42,063
| -92% | -$1.31M |
2022 Q4
8 quarters
|
|
|
JFIN
11248
Jiayin Group
JFIN
$71.2M
| $113K | ﹤0.01% |
17,739
-34,345
| -66% | -$230K |
2022 Q3
9 quarters
|
|
11249
iShares MSCI KLD 400 Social ETF
DSI
$5.58B
| $113K | ﹤0.01% |
+1,024
| New | +$114K |
2024 Q4
0 quarters
|
|
|
CGAU
11250
CALL
Centerra Gold
CGAU
$4.14B
| $113K | ﹤0.01% |
19,800
-33,200
| -63% | -$213K |
2022 Q1
11 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.